Many biologics, including blockbusters like Epogen/Procrit, are nearing patent expiration, and generics manufacturers, including Sicor (acquired by Teva), Barr Laboratories, and Ivax Corporation, are hoping to market generic biologics.
July 08, 2024
June 18, 2024
June 07, 2024
June 06, 2024
May 31, 2024
May 20, 2024
May 10, 2024